Login / Signup

TRIM21 suppresses CHK1 activation by preferentially targeting CLASPIN for K63-linked ubiquitination.

Xuefei ZhuJingwei XueXing JiangYamin GongCongwen GaoTing CaoQian LiLulu BaiYuwei LiGaixia XuBin PengXingzhi Xu
Published in: Nucleic acids research (2022)
Expression of the E3 ligase TRIM21 is increased in a broad spectrum of cancers; however, the functionally relevant molecular pathway targeted by TRIM21 overexpression remains largely unknown. Here, we show that TRIM21 directly interacts with and ubiquitinates CLASPIN, a mediator for ATR-dependent CHK1 activation. TRIM21-mediated K63-linked ubiquitination of CLASPIN counteracts the K6-linked ubiquitination of CLASPIN which is essential for its interaction with TIPIN and subsequent chromatin loading. We further show that overexpression of TRIM21, but not a TRIM21 catalytically inactive mutant, compromises CHK1 activation, leading to replication fork instability and tumorigenesis. Our findings demonstrate that TRIM21 suppresses CHK1 activation by preferentially targeting CLASPIN for K63-linked ubiquitination, providing a potential target for cancer therapy.
Keyphrases
  • cancer therapy
  • dna damage response
  • transcription factor
  • poor prognosis
  • cell proliferation
  • gene expression
  • drug delivery
  • dna damage
  • oxidative stress
  • long non coding rna
  • young adults
  • single molecule